CPT 55868 Radical Prostatectomy Reimbursement

CPT code 55868 represents a laparoscopic retropubic radical prostatectomy that employs nerve‑sparing techniques and may use robotic assistance, with limited pelvic lymph node sampling for staging. This procedure is a cornerstone surgical option for clinically localized prostate cancer and is nationally significant due to its implications for cancer control, functional outcomes (continence and erectile function), and perioperative resource use. The code signals both the primary extirpative operation and limited lymph node evaluation, which affects operative planning and coding specificity.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, payer coverage themes, and typical sites of service. The publication outlines common billing considerations and related procedural grouping, benchmarks for utilization and site‑of‑service patterns, and recent policy developments that influence authorization and payment for minimally invasive prostatectomy approaches. The summary also highlights areas where coding detail matters for claims processing, including documentation of nerve‑sparing intent and lymph node sampling.

This national overview is designed for revenue cycle leaders, surgical practices, and health policy analysts seeking clear, actionable understanding of CPT code 55868 in clinical and payer contexts.

Billing Code Overview

CPT code 55868 describes a laparoscopic retropubic radical prostatectomy with nerve‑sparing techniques and may include robotic assistance. The procedure includes removal of the prostate gland and limited pelvic lymph node sampling for biopsy to assess possible cancer spread.

Service type: Surgical — Urology / Oncologic Surgery

Typical site of service: Hospital outpatient surgical suite or ambulatory surgery center, with possible inpatient admission depending on clinical course.

Clinical Context

A 64-year-old male with biopsy-proven, clinically localized prostate adenocarcinoma presents for definitive surgical management. Preoperative staging includes multiparametric prostate MRI showing a lesion confined to the prostate and pelvic imaging without distant metastases. PSA is progressively rising over serial measurements. After shared decision-making, the urologic oncology team schedules a laparoscopic retropubic radical prostatectomy with bilateral nerve-sparing technique and limited pelvic lymph node sampling for pathologic staging. The typical workflow includes preoperative evaluation and optimization (history, medication reconciliation, anesthesia assessment, and informed consent), perioperative antibiotic prophylaxis, general endotracheal anesthesia, patient positioning in Trendelenburg, laparoscopic port placement with or without robotic assistance, retropubic dissection of the prostate with preservation of neurovascular bundles when oncologically appropriate, bilateral pelvic lymph node sampling, specimen retrieval, hemostasis, drain placement if indicated, and postoperative recovery with catheter management and pathology review to guide adjuvant therapy decisions.

Coding Specifications

Modifier	Description	When to Use
`50`	Bilateral procedure	Not typically used; prostatectomy is a single midline organ procedure and `50` is not applicable.

Taxonomy Code	Specialty	Notes
`2080S0005X`	Urology	Board-certified urologists perform radical prostatectomy.
`2080P0207X`	Urology - Oncology	Urologic oncologists often perform complex prostate cancer surgeries.
`363L00000X`	Surgery - Robotic Surgeon	Surgeons with robotic surgery focus may perform robotic-assisted laparoscopic prostatectomy.
`208D00000X`	General Surgery	Some surgeons with appropriate training may perform pelvic oncologic procedures in specific settings.
`207R00000X`	Thoracic Surgery	Data not typical for this procedure but included when multidisciplinary pelvic procedures occur — Data not available in the input.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C61`	Malignant neoplasm of prostate	Primary oncologic indication for radical prostatectomy; denotes localized prostate cancer appropriate for surgical management.
`N40`	Benign prostatic hyperplasia	Differential diagnosis; may coexist but is not the indication for radical prostatectomy for cancer.
`R97.2`	Elevated prostate specific antigen [PSA]	Common preoperative finding prompting biopsy and definitive treatment.
`Z85.46`	Personal history of malignant neoplasm of prostate	Relevant for surveillance and for coding when prior prostate cancer treatment occurred.
`C79.51`	Secondary malignant neoplasm of bone	Important exclusion — presence of distant metastasis would typically alter management away from radical prostatectomy.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`55866`	Laparoscopic radical prostatectomy, retropubic, with pelvic lymph node dissection (complete)	Represents an open or non-nerve-sparing variation with more extensive lymph node dissection; may be billed when a more extensive PLND is performed instead of limited sampling.
`55845`	Laparoscopy, surgical prostatectomy, simple (e.g., for benign prostatic hyperplasia)	Distinct from radical prostatectomy; used for benign disease rather than oncologic resection.
`55250`	Biopsy of the prostate, needle, transperineal or transrectal, single or multiple cores	Often performed preoperatively for diagnosis and may have been done in the diagnostic workup leading to the radical prostatectomy.
`38900`	Lymph node, open biopsy, superficial; single node	Used for standalone lymph node biopsy when limited sampling is performed separately from prostatectomy.
`51701`	Insertion of temporary indwelling urethral catheter	Typically performed intraoperatively or postoperatively for urinary drainage after prostatectomy.

OpenPayer

Summary & Overview

CPT 55868: Laparoscopic Retropubic Radical Prostatectomy, Nerve‑Sparing